Biodegradable-polymer-based, paclitaxel eluting infinnium, stent, 9-month clinical, angiographic follow-up, results from the SIMPLE II, prospective, multi-centre, registry study,
 

EVPU

Home About Us Products R & D Clinical Trials Media Publications Contact Us
      HOME
Quick Search:
Latest News
Surat, India - June 26, 2011 - Sahajanand Medical Technologies (SMT) announced today that it has received European CE marking for two Sirolimus eluting coronary stent systems; Supralimus® (Sirolimus eluting stents on stainless steel...
Read More...
Surat, India - April 15, 2011 - An entrepreneur from India, Mr. DhirajLal Kotadia, Chairman of Sahajanand Group, has honored the prestigious “Pride of India Leadership Award” for his contribution in human health and...
Read More...
 
 Products Overview
Supralimus-Core™ (CE approved) Sirolimus Eluting Coronary Stent System is based on the three powerful... Learn More...  
The Supralimus® (CE approved) is based on the three powerful tools. The CE approved The Millennium Matrix® Stent... Learn More...  
Indolimus® (CE approved) Sirolimus Eluting Coronary Stent System is based on the three powerful... Learn More...  
The Coronnium® (CE approved) Cobalt Chromium Coronary Stent System contains... Learn More...  
The Infinnium® (CE approved) Paclitaxel Eluting Coronary Stent System contains Biodegradable... Learn More...  
The Millennium Matrix® (CE approved) Coronary Stent System contains excellent technical features like... Learn More...  
Ergonomically designed to ensure accurate inflation of interventional devices. Learn More...  
Supralimus and Supralimus-Core - now with CE mark
Sahajanand Medical Technologies Pvt. Ltd. - "Sahajanand Estate", Wakhariawadi, Nr. Dabholi Char Rasta, Ved Road, Surat - 395004 (Guj.), India
Tel: +91-261-3060606 Fax: +91-261-3060607 © Copyright 2008. All rights reserved. Last Update: 2013/06/19